Cargando…
EXCHANGE-2: investigating the efficacy of add-on plasma exchange as an adjunctive strategy against septic shock—a study protocol for a randomized, prospective, multicenter, open-label, controlled, parallel-group trial
BACKGROUND: Sepsis is as a life-threatening organ dysfunction caused by a dysregulated host response to an infection. The mortality of sepsis and particular of septic shock is very high. Treatment mostly focuses on infection control but a specific intervention that targets the underlying pathologica...
Autores principales: | David, Sascha, Bode, Christian, Stahl, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105400/ https://www.ncbi.nlm.nih.gov/pubmed/37061693 http://dx.doi.org/10.1186/s13063-023-07300-5 |
Ejemplares similares
-
Adjuvant therapeutic plasma exchange in septic shock
por: David, Sascha, et al.
Publicado: (2021) -
Effects of therapeutic plasma exchange on the endothelial glycocalyx in septic shock
por: Stahl, Klaus, et al.
Publicado: (2021) -
Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock
por: Stahl, Klaus, et al.
Publicado: (2020) -
Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers
por: Knaup, Hannah, et al.
Publicado: (2018) -
Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial
por: Stahl, Klaus, et al.
Publicado: (2022)